作为治疗点的核表皮生长因子受体
Benjamin Atwell1, Pavani Chalasani2,3, Joyce Schroeder1,3,4
1Department of Molecular and Cellular Biology, University of Arizona, Tucson, AZ 85721, USA.
皮表皮生长因子受体 (EGFR) 疗法表现有前途,但面临阻力. 针对核EGFR (nEGFR) 的新型基治疗提供了新的希望,特别是在三阴性乳腺癌 (TNBC) 中.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 皮表皮生长因子受体 (EGFR) 是一个关键的瘤基因,与癌症扩散,转移和治疗耐药性有关.
- 目前针对EGFR的疗法,包括TKIs和抗体,对野生型和突变EGFR有效,但面临诸如获得的耐药性和某些癌症的无效性等挑战,例如三阴性乳腺癌 (TNBC).
研究的目的:
- 审查目前针对EGFR的治疗方法,并探索旨在阻断核EGFR (nEGFR) 的新型基于的治疗方法.
- 讨论这些新型疗法在瘤学中的临床应用和潜力,特别是对于EGFR表现出核局部化的TNBC.
主要方法:
- 对现有的EGFR向疗法及其机制的文献综述.
- 探索针对EGFR的核定位和功能的新兴基疗法.
- 分析临床数据和各种癌症类型的潜在应用.
主要成果:
- EGFR在转录,DNA修复和TNBC中的化学抵抗等核功能中的作用.
- 核定位EGFR (nEGFR) 与转移性疾病和预后不佳有关.
- 新型基于的疗法显示出阻断nEGFR活性的潜力.
结论:
- 目前的EGFR疗法存在局限性,特别是在TNBC中,因为核EGFR.
- 针对核EGFR提出了一个有希望的新战略,以克服治疗耐药性.
- 基于的疗法为抑制nEGFR提供了一种新的方法,有可能改善癌症治疗结果.
更多相关视频
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
09:16Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
Published on: September 11, 2015
相关概念视频
Mitogens and the Cell Cycle
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Targeted Cancer Therapies
There are several types of targeted therapies against...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
